ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd.verified

IPA

Price:

$1.62

Market Cap:

$79.44M

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, V...[Read more]

Industry

Biotechnology

IPO Date

2002-01-07

Stock Exchange

NASDAQ

Ticker

IPA

The Enterprise Value as of March 2026 (TTM) for ImmunoPrecise Antibodies Ltd. (IPA) is 66.55M

According to ImmunoPrecise Antibodies Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 66.55M. This represents a change of 9.60% compared to the average of 60.72M of the last 4 quarters.

ImmunoPrecise Antibodies Ltd. (IPA) Historical Enterprise Value (quarterly & annually)

How has IPA Enterprise Value performed in the past?

The mean historical Enterprise Value of ImmunoPrecise Antibodies Ltd. over the last ten years is 61.54M. The current 66.55M Enterprise Value has changed 10.71% with respect to the historical average. Over the past ten years (40 quarters), IPA's Enterprise Value was at its highest in in the January 2021 quarter at 342.31M. The Enterprise Value was at its lowest in in the March 2016 quarter at 3.21M.

Quarterly (TTM)
Annual

Average

61.54M

Median

51.03M

Minimum

10.65M

Maximum

159.11M

ImmunoPrecise Antibodies Ltd. (IPA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ImmunoPrecise Antibodies Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 271.21%

Maximum Annual Enterprise Value = 159.11M

Minimum Annual Increase = -58.67%

Minimum Annual Enterprise Value = 10.65M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202522.91M-58.67%
202455.43M-35.35%
202385.75M-24.48%
2022113.54M-28.64%
2021159.11M190.69%
202054.74M15.66%
201947.33M3.43%
201845.75M126.17%
201720.23M90.00%
201610.65M271.21%

ImmunoPrecise Antibodies Ltd. (IPA) Average Enterprise Value

How has IPA Enterprise Value performed in the past?

The current Enterprise Value of ImmunoPrecise Antibodies Ltd. (IPA) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

54.70M

5-year avg

87.35M

10-year avg

61.54M

ImmunoPrecise Antibodies Ltd. (IPA) Enterprise Value vs. Peers

How is IPA’s Enterprise Value compared to its peers?

ImmunoPrecise Antibodies Ltd.’s Enterprise Value is greater than IGM Biosciences, Inc. (46.85M), less than Jade Biosciences, Inc. (366.44M), greater than Quince Therapeutics, Inc. (17.47M), greater than Landos Biopharma, Inc. (34.13M), less than Surface Oncology, Inc. (70.21M), less than Heat Biologics, Inc. (17.53T), greater than Berkeley Lights, Inc. (42.64M), greater than Reneo Pharmaceuticals, Inc. (2.34M), greater than Achilles Therapeutics plc (-66096000.00), less than Miromatrix Medical Inc. (91.30M),

Build a custom stock screener for ImmunoPrecise Antibodies Ltd. (IPA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmunoPrecise Antibodies Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmunoPrecise Antibodies Ltd. (IPA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmunoPrecise Antibodies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ImmunoPrecise Antibodies Ltd.'s Enterprise Value?

What is the highest Enterprise Value for ImmunoPrecise Antibodies Ltd. (IPA)?

What is the 3-year average Enterprise Value for ImmunoPrecise Antibodies Ltd. (IPA)?

What is the 5-year average Enterprise Value for ImmunoPrecise Antibodies Ltd. (IPA)?

How does the current Enterprise Value for ImmunoPrecise Antibodies Ltd. (IPA) compare to its historical average?